These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6378022)

  • 1. Use of flow microfluorometry in bone marrow transplantation.
    Martin PJ; Hansen JA; Thomas ED
    Ann N Y Acad Sci; 1984; 428():14-25. PubMed ID: 6378022
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibody.
    Hoffman AL; Makowka L; Cramer DV; Cai X; Pascualone A; Banner BF; Sheahan DG; Rettinger P; Starzl TE
    J Invest Surg; 1989; 2(3):241-51. PubMed ID: 2487253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of graft versus host disease by in vitro immunodepletion of the graft].
    Maraninchi D
    Nouv Rev Fr Hematol (1978); 1985; 27(6):349-50. PubMed ID: 3912729
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
    Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE
    Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
    [No Abstract]   [Full Text] [Related]  

  • 5. New approaches to graft engineering for haploidentical bone marrow transplantation.
    Handgretinger R
    Semin Oncol; 2012 Dec; 39(6):664-73. PubMed ID: 23206843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
    Champlin R
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantation.
    Tiberghien P; Hervé P
    Transfus Sci; 1992; 13(4):443-54. PubMed ID: 10147740
    [No Abstract]   [Full Text] [Related]  

  • 9. [T cell depletion for allogeneic bone marrow transplantation].
    Morishima Y
    Nihon Rinsho; 1990 Sep; 48(9):1971-6. PubMed ID: 2232199
    [No Abstract]   [Full Text] [Related]  

  • 10. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
    Ringdén O; Deeg HJ; Beschorner W; Slavin S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
    [No Abstract]   [Full Text] [Related]  

  • 11. T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias.
    Aversa F; Terenzi A; Carotti A; Velardi A; Latini P; Gambelunghe C; Grignani F; Martelli MF
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():69-72. PubMed ID: 2697440
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of graft versus host disease by in vitro depletion of T lymphocytes with monoclonal antibodies (Campath-1) in patients undergoing bone marrow transplantation].
    Iriondo A; Richard C; Hermosa V; Conde E; Garijo J; Cuadrado MA; Bello C; Muruzábal MJ; Pérez-Encinas M; Zubizarreta A
    Med Clin (Barc); 1988 Oct; 91(13):488-92. PubMed ID: 3067007
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
    Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte depletion in bone marrow transplantation: will modulation of graft-versus-host disease prove to be superior to prevention?
    Noga SJ; Hess AD
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):28-33. PubMed ID: 8211214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical problems associated with T cell depletion for bone marrow transplantation.
    Bacigalupo A; Van Lint MT; Frassoni F; Occhini D; Pittaluga PA; Piaggio G; Figari O; Marmont AM
    Ann N Y Acad Sci; 1987; 511():459-63. PubMed ID: 3326474
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory control in predicting clinical efficacy of T cell-depletion procedures used for prevention of graft-versus-host disease: importance of limiting dilution analysis.
    Marciniak E; Romond EH; Thompson JS; Henslee PJ
    Bone Marrow Transplant; 1988 Nov; 3(6):589-98. PubMed ID: 3063328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative determination of human bone marrow T cells following in vitro depletion by Campath-1 monoclonal antibody].
    Irlé C; Kaestli M; Chapuis B; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1517-8. PubMed ID: 3909385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppression and the problems in homologous bone marrow transplantation].
    Yabe H; Kato S
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):681-2. PubMed ID: 8963784
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of graft-versus-host disease by using immunotoxins.
    Laurent G; Bouloux C
    Prog Clin Biol Res; 1992; 377():129-36; discussion 137. PubMed ID: 1438408
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction.
    Llull R; Murase N; Ye Q; Manez R; Demetris AJ; Fournier V; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):164-5. PubMed ID: 7878956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.